Kusajili – Clinical trials directory

Result of your search per sponsor: Bertrand GODEAU, MD

Woman and Man Max 99 years
Bertrand GODEAU, MD Update Il y a 4 ans

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia The primary purpose of the study is to describe by a prospective observational study the serious adverse events occurring in patients treated off-label by rituximab for Immune Thrombocytop...

Country France
organs None
Specialty None

unknown

More information